Preparation method of (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1

background and overview[1] ezetimibe was jointly developed by schering-plough and merck for the treatment of hyperlipidemia. it was approved by the us fda for marketing in 2002 under the trade name ze…